Lovelace Biomedical Presents a New Webinar on Rare Diseases and Gene Therapy Preclinical Research
November 3, 2021
ALBUQUERQUE, N.M., Oct. 21, 2021 /PRNewswire/ — Lovelace Biomedical, a contract research organization, who has a vast and storied, 70 plus year history and expertise in studying respiratory diseases and developing therapeutics at the preclinical stage, will present a webinar in gene therapies for diseases, and will use Cystic Fibrosis results as a case study.
Read the source article at News Nation USA
2021-10-21 23:19:00
